Multi-omics analysis of small extracellular vesicles in osteoarthritis: bridging the gap between molecular insights and clinical applications

Abstract

Osteoarthritis (OA) is a prevalent degenerative joint disorder with significant socioeconomic impact. Despite advances in understanding its pathophysiology, current therapeutic strategies remain largely palliative. Small extracellular vesicles (sEV) have emerged as crucial mediators of intercellular communication in joint tissues, offering new insights into OA pathogenesis and potential therapeutic targets. This review explores the application of multi-omics approaches to sEV research in OA, assessing how these advanced technologies are contributing to our understanding of the disease and their potential to revolutionize OA management. We discuss the latest findings on the role of sEV in OA, the applications of multi-omics technologies in deciphering sEV cargo, the progress toward clinical translation, and the challenges and opportunities in this field. By synthesizing current knowledge and identifying key research gaps, this review provides a roadmap for leveraging sEV multi-omics to bridge the gap between molecular discoveries and clinical applications in OA.

Keywords

Small extracellular vesicles / Multi-omics / Osteoarthritis

References

[1] Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet 2019; 393: 1745-59. https://doi.org/10.1016/s0140-6736(19)30417-9.

[2] Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA 2021; 325: 568-78. https://doi.org/10.1001/jama.2020.22171.

[3] Conaghan PG, Cook AD, Hamilton JA, Tak PP. Therapeutic options for targeting inflammatory osteoarthritis pain. Nat Rev Rheumatol 2019; 15: 355-63. https://doi.org/10.1038/s41584-019-0221-y.

[4] Arden NK, Perry TA, Bannuru RR, Bruyère O, Cooper C, Haugen IK, et al. Non-surgical management of knee osteoarthritis: comparison of esceo and oarsi 2019 guidelines. Nat Rev Rheumatol 2021; 17: 59-66. https://doi.org/10.1038/s41584-020-00523-9.

[5] Karsdal MA, Michaelis M, Ladel C, Siebuhr AS, Bihlet AR, Andersen JR, et al. Disease-modifying treatments for osteoarthritis (dmoads) of the knee and hip: lessons learned from failures and opportunities for the future. Osteoarthr Cartil 2016; 24: 2013-21. https://doi.org/10.1016/j.joca.2016.07.017.

[6] Mahmoudian A, Lohmander LS, Mobasheri A, Englund M, Luyten FP. Early-stage symptomatic osteoarthritis of the knee-time for action. Nat Rev Rheumatol 2021; 17: 621-32. https://doi.org/10.1038/s41584-021-00673-4.

[7] Ma Q, Liang M, Wu Y, Dou C, Xu J, Dong S, et al. Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche. J Extracell Vesicles 2021; 10: e12068. https://doi.org/10.1002/jev2.12068.

[8] Dogra N, Chen TY, Gonzalez-Kozlova E, Miceli R, Cordon-Cardo C, Tewari AK, et al. Extracellular vesicles carry transcriptional ‘dark matter’ revealing tissue-specific information. J Extracell Vesicles 2024; 13: e12481. https://doi.org/10.1002/jev2.12481.

[9] Cao Y, Ruan J, Kang J, Nie X, Lan W, Ruan G, et al. Extracellular vesicles in infrapatellar fat pad from osteoarthritis patients impair cartilage metabolism and induce senescence. Adv Sci (Weinh) 2024; 11: e2303614. https://doi.org/10.1002/advs.202303614.

[10] Couch Y, Buzàs EI, Di Vizio D, Gho YS, Harrison P, Hill AF, et al. A brief history of nearly everything-the rise and rise of extracellular vesicles. J Extracell Vesicles 2021; 10: e12144. https://doi.org/10.1002/jev2.12144.

[11] Ebata T, Terkawi MA, Kitahara K, Yokota S, Shiota J, Nishida Y, et al. Noncanonical pyroptosis triggered by macrophage-derived extracellular vesicles in chondrocytes leading to cartilage catabolism in osteoarthritis. Arthritis Rheumatol. 2023; 75: 1358-69. https://doi.org/10.1002/art.42505.

[12] Hanai H, Hart DA, Jacob G, Shimomura K, Ando W, Yoshioka Y, et al. Small extracellular vesicles derived from human adipose-derived mesenchymal stromal cells cultured in a new chemically-defined contaminate-free media exhibit enhanced biological and therapeutic effects on human chondrocytes in vitro and in a mouse osteoarthritis model. J Extracell Vesicles 2023; 12: e12337. https://doi.org/10.1002/jev2.12337.

[13] Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biol 2017; 18: 83. https://doi.org/10.1186/s13059-017-1215-1.

[14] Karczewski KJ, Snyder MP. Integrative omics for health and disease. Nat Rev Genet 2018; 19: 299-310. https://doi.org/10.1038/nrg.2018.4.

[15] Anderson JR, Johnson E, Jenkins R, Jacobsen S, Green D, Walters M, et al. Multi-omic temporal landscape of plasma and synovial fluid-derived extracellular vesicles using an experimental model of equine osteoarthritis. Int J Mol Sci 2023; 24: 14888. https://doi.org/10.3390/ijms241914888.

[16] Clarke E, Varela L, Jenkins RE, Lozano-Andrés E, Cywińska A, Przewozny M, et al. Proteome and phospholipidome interrelationship of synovial fluid-derived extracellular vesicles in equine osteoarthritis: an exploratory ‘multi-omics’ study to identify composite biomarkers. Biochem Biophys Rep 2024; 37: 101635. https://doi.org/10.1016/j.bbrep.2023.101635.

[17] Liu Z, Zhuang Y, Fang L, Yuan C, Wang X, Lin K. Breakthrough of extracellular vesicles in pathogenesis, diagnosis and treatment of osteoarthritis. Bioact Mater 2023; 22: 423-52. https://doi.org/10.1016/j.bioactmat.2022.10.012.

[18] Witwer KW, Van Balkom BWM, Bruno S, Choo A, Dominici M, Gimona M, et al. Defining mesenchymal stromal cell (msc)-derived small extracellular vesicles for therapeutic applications. J Extracell Vesicles 2019; 8: 1609206. https://doi.org/10.1080/20013078.2019.1609206.

[19] Gimona M, Brizzi MF, Choo ABH, Dominici M, Davidson SM, Grillari J, et al. Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles. Cytotherapy 2021; 23: 373-80. https://doi.org/10.1016/j.jcyt.2021.01.001.

[20] Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mrnas and micrornas is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654- 9. https://doi.org/10.1038/ncb1596.

[21] Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport rna and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10: 1470-6. https://doi.org/10.1038/ncb1800.

[22] Cheng L, Hill AF. Therapeutically harnessing extracellular vesicles. Nat Rev Drug Discov 2022; 21: 379-99. https://doi.org/10.1038/s41573-022-00410-w.

[23] Buzas EI. The roles of extracellular vesicles in the immune system. Nat Rev Immunol 2023; 23: 236-50. https://doi.org/10.1038/s41577-022-00763-8.

[24] Welsh JA, Goberdhan DCI, O’Driscoll L, Buzas EI, Blenkiron C, Bussolati B, et al. Minimal information for studies of extracellular vesicles (misev2023): from basic to advanced approaches. J Extracell Vesicles 2024; 13: e12404. https://doi.org/10.1002/jev2.12404.

[25] Sansone P, Savini C, Kurelac I, Chang Q, Amato LB, Strillacci A, et al. Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer. Proc Natl Acad Sci USA 2017; 114: E9066-75. https://doi.org/10.1073/pnas.1704862114.

[26] Torralba D, Baixauli F, Villarroya-Beltri C, Fernández-Delgado I, Latorre-Pellicer A, Acín-Pérez R, et al. Priming of dendritic cells by DNA-containing extracellular vesicles from activated t cells through antigen-driven contacts. Nat Commun 2018; 9: 2658. https://doi.org/10.1038/s41467-018-05077-9.

[27] Thakur BK, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res 2014; 24: 766-9. https://doi.org/10.1038/cr.2014.44.

[28] Vagner T, Spinelli C, Minciacchi VR, Balaj L, Zandian M, Conley A, et al. Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma. J Extracell Vesicles 2018; 7: 1505403. https://doi.org/10.1080/20013078.2018.1505403.

[29] Van Hoof R, Deville S, Hollanders K, Berckmans P, Wagner P, Hooyberghs J, et al. Intravesicular genomic DNA enriched by size exclusion chromatography can enhance lung cancer oncogene mutation detection sensitivity. Int J Mol Sci 2022; 23: 16052. https://doi.org/10.3390/ijms232416052.

[30] Moldovan N, Verkuijlen S, van der Pol Y, Bosch L, van Weering JRT, Bahce I, et al. Comparison of cell-free and small extracellular-vesicle-associated DNA by sequencing plasma of lung cancer patients. iScience 2024; 27: 110742. https://doi.org/10.1016/j.isci.2024.110742.

[31] Lee SE, Park HY, Hur JY, Kim HJ, Kim IA, Kim WS, et al. Genomic profiling of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid of patients with lung adenocarcinoma. Transl Lung Cancer Res 2021; 10: 104-16. https://doi.org/10.21037/tlcr-20-888.

[32] Qian Z, Shen Q, Yang X, Qiu Y, Zhang W. The role of extracellular vesicles: an epigenetic view of the cancer microenvironment. Biomed Res Int 2015; 2015: 649161. https://doi.org/10.1155/2015/649161.

[33] Huang G, Cheng Z, Hildebrand A, Wang C, Cimini M, Roy R, et al. Diabetes impairs cardioprotective function of endothelial progenitor cell-derived extracellular vesicles via h3k9ac inhibition. Theranostics 2022; 12: 4415-30. https://doi.org/10.7150/thno.70821.

[34] Buschmann D, Kirchner B, Hermann S, Märte M, Wurmser C, Brandes F, et al. Evaluation of serum extracellular vesicle isolation methods for profiling mirnas by next-generation sequencing. J Extracell Vesicles 2018; 7: 1481321. https://doi.org/10.1080/20013078.2018.1481321.

[35] Mateescu B, Kowal EJ, van Balkom BW, Bartel S, Bhattacharyya SN, Buzás EI, et al. Obstacles and opportunities in the functional analysis of extracellular vesicle rna-an isev position paper. J Extracell Vesicles 2017; 6: 1286095. https://doi.org/10.1080/20013078.2017.1286095.

[36] Squadrito ML, Baer C, Burdet F, Maderna C, Gilfillan GD, Lyle R, et al. Endogenous rnas modulate microrna sorting to exosomes and transfer to acceptor cells. Cell Rep 2014; 8: 1432-46. https://doi.org/10.1016/j.celrep.2014.07.035.

[37] Wang T, Zhao H, Zhang Y, Liu Y, Liu J, Chen G, et al. A novel extracellular vesicles production system harnessing matrix homeostasis and macrophage reprogramming mitigates osteoarthritis. J Nanobiotechnol 2024; 22: 79. https://doi.org/10.1186/s12951-024-02324-8.

[38] Garcia-Martin R, Wang G, Brandão BB, Zanotto TM, Shah S, Kumar Patel S, et al. Microrna sequence codes for small extracellular vesicle release and cellular retention. Nature 2022; 601: 446-51. https://doi.org/10.1038/s41586-021-04234-3.

[39] Xiao X, Xu M, Yu H, Wang L, Li X, Rak J, et al. Mesenchymal stem cell-derived small extracellular vesicles mitigate oxidative stress-induced senescence in endothelial cells via regulation of mir-146a/src. Signal Transduct Target Ther 2021; 6: 354. https://doi.org/10.1038/s41392-021-00765-3.

[40] Chen X, Chen S, Pang J, Huang R, You Y, Zhang H, et al. Hepatic steatosis aggravates atherosclerosis via small extracellular vesicle-mediated inhibition of cellular cholesterol efflux. J Hepatol 2023; 79: 1491-501. https://doi.org/10.1016/j.jhep.2023.08.023.

[41] Koide T, Mandai S, Kitaoka R, Matsuki H, Chiga M, Yamamoto K, et al. Circulating extracellular vesicle-propagated microrna signature as a vascular calcification factor in chronic kidney disease. Circ Res 2023; 132: 415-31. https://doi.org/10.1161/circresaha.122.321939.

[42] Cheng L, Sharples RA, Scicluna BJ, Hill AF. Exosomes provide a protective and enriched source of mirna for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles 2014; 3: 3. https://doi.org/10.3402/jev.v3.23743.

[43] Xue M, Chen W, Xiang A, Wang R, Chen H, Pan J, et al. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding rna-uca1. Mol Cancer 2017; 16: 143. https://doi.org/10.1186/s12943-017-0714-8.

[44] Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J, et al. Circular rna is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res 2015; 25: 981-4. https://doi.org/10.1038/cr.2015.82.

[45] Lässer C, Shelke GV, Yeri A, Kim DK, Crescitelli R, Raimondo S, et al. Two distinct extracellular rna signatures released by a single cell type identified by microarray and next-generation sequencing. RNA Biol 2017; 14: 58-72. https://doi.org/10.1080/15476286.2016.1249092.

[46] Kalra H, Adda CG, Liem M, Ang CS, Mechler A, Simpson RJ, et al. Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma. Proteomics 2013; 13: 3354-64. https://doi.org/10.1002/pmic.201300282.

[47] Keerthikumar S, Chisanga D, Ariyaratne D, Al Saffar H, Anand S, Zhao K, et al. Exocarta: a web-based compendium of exosomal cargo. J Mol Biol 2016; 428: 688-92. https://doi.org/10.1016/j.jmb.2015.09.019.

[48] Nguyen HQ, Lee D, Kim Y, Bang G, Cho K, Lee YS, et al. Label-free quantitative proteomic analysis of serum extracellular vesicles differentiating patients of alcoholic and nonalcoholic fatty liver diseases. J Proteome 2021; 245: 104278. https://doi.org/10.1016/j.jprot.2021.104278.

[49] Manouchehri Doulabi E, Fredolini C, Gallini R, Löf L, Shen Q, Ikebuchi R, et al. Surface protein profiling of prostate-derived extracellular vesicles by mass spectrometry and proximity assays. Commun Biol 2022; 5: 1402. https://doi.org/10.1038/s42003-022-04349-x.

[50] Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, et al. Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells. Proteomics 2023; 23: e2200204. https://doi.org/10.1002/pmic.202200204.

[51] Nguyen HQ, Lee D, Kim Y, Paek M, Kim M, Jang KS, et al. Platelet factor 4 as a novel exosome marker in maldi-ms analysis of exosomes from human serum. Anal Chem 2019; 91: 13297-305. https://doi.org/10.1021/acs.analchem.9b04198.

[52] Webber J, Stone TC, Katilius E, Smith BC, Gordon B, Mason MD, et al. Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (somascan™) platform. Mol Cell Proteomics 2014; 13: 1050-64. https://doi.org/10.1074/mcp.M113.032136.

[53] Bæk R, Søndergaard EK, Varming K, Jørgensen MM. The impact of various preanalytical treatments on the phenotype of small extracellular vesicles in blood analyzed by protein microarray. J Immunol Methods 2016; 438: 11-20. https://doi.org/10.1016/j.jim.2016.08.007.

[54] Moreno-Gonzalo O, Fernandez-Delgado I, Sanchez-Madrid F. Post-translational add-ons mark the path in exosomal protein sorting. Cell Mol Life Sci 2018; 75: 1-19. https://doi.org/10.1007/s00018-017-2690-y.

[55] Ageta H, Ageta-Ishihara N, Hitachi K, Karayel O, Onouchi T, Yamaguchi H, et al. Ubl3 modification influences protein sorting to small extracellular vesicles. Nat Commun 2018; 9: 3936. https://doi.org/10.1038/s41467-018-06197-y.

[56] Telekawa C, Boisvert FM, Bachand F. Proteomic profiling and functional characterization of post-translational modifications of the fission yeast rna exosome. Nucleic Acids Res 2018; 46: 11169-83. https://doi.org/10.1093/nar/gky915.

[57] Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R, et al. Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol 2009; 20: 363-79. https://doi.org/10.1681/asn.2008040406.

[58] Andaluz Aguilar H, Iliuk AB, Chen IH, Tao WA. Sequential phosphoproteomics and n-glycoproteomics of plasma-derived extracellular vesicles. Nat Protoc 2020; 15: 161-80. https://doi.org/10.1038/s41596-019-0260-5.

[59] Vrablova V, Kosutova N, Blsakova A, Bertokova A, Kasak P, Bertok T, et al. Glycosylation in extracellular vesicles: isolation, characterization, composition, analysis and clinical applications. Biotechnol Adv 2023; 67: 108196. https://doi.org/10.1016/j.biotechadv.2023.108196.

[60] Haraszti RA, Didiot MC, Sapp E, Leszyk J, Shaffer SA, Rockwell HE, et al. High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J Extracell Vesicles 2016; 5: 32570. https://doi.org/10.3402/jev.v5.32570.

[61] Palviainen M, Saari H, Kärkkäinen O, Pekkinen J, Auriola S, Yliperttula M, et al. Metabolic signature of extracellular vesicles depends on the cell culture conditions. J Extracell Vesicles 2019; 8: 1596669. https://doi.org/10.1080/20013078.2019.1596669.

[62] Mohieldin AM, Pala R, Beuttler R, Moresco JJ, Yates JR 3rd, Nauli SM. Ciliary extracellular vesicles are distinct from the cytosolic extracellular vesicles. J Extracell Vesicles 2021; 10: e12086. https://doi.org/10.1002/jev2.12086.

[63] Lou D, Shi K, Li HP, Zhu Q, Hu L, Luo J, et al. Quantitative metabolic analysis of plasma extracellular vesicles for the diagnosis of severe acute pancreatitis. J Nanobiotechnol. 2022; 20: 52. https://doi.org/10.1186/s12951-022-01239-6.

[64] Luo P, Mao K, Xu J, Wu F, Wang X, Wang S, et al. Metabolic characteristics of large and small extracellular vesicles from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy. J Extracell Vesicles 2020; 9: 1790158. https://doi.org/10.1080/20013078.2020.1790158.

[65] Lokumcu T, Iskar M, Schneider M, Helm D, Klinke G, Schlicker L, et al. Proteomic, metabolomic, and fatty acid profiling of small extracellular vesicles from glioblastoma stem-like cells and their role in tumor heterogeneity. ACS Nano 2024; 18: 2500-19. https://doi.org/10.1021/acsnano.3c11427.

[66] Carayon K, Chaoui K, Ronzier E, Lazar I, Bertrand-Michel J, Roques V, et al. Proteolipidic composition of exosomes changes during reticulocyte maturation. J Biol Chem 2011; 286: 34426-39. https://doi.org/10.1074/jbc.M111.257444.

[67] Zhang H, Freitas D, Kim HS, Fabijanic K, Li Z, Chen H, et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol 2018; 20: 332-43. https://doi.org/10.1038/s41556-018-0040-4.

[68] Dixson AC, Dawson TR, Di Vizio D, Weaver AM. Context-specific regulation of extracellular vesicle biogenesis and cargo selection. Nat Rev Mol Cell Biol 2023; 24: 454-76. https://doi.org/10.1038/s41580-023-00576-0.

[69] Su H, Rustam YH, Masters CL, Makalic E, McLean CA, Hill AF, et al. Characterization of brain-derived extracellular vesicle lipids in Alzheimer’s disease. J Extracell Vesicles 2021; 10: e12089. https://doi.org/10.1002/jev2.12089.

[70] Cioanca AV, Wooff Y, Aggio-Bruce R, Sekar R, Dietrich C, Natoli R. Multiomic integration reveals neuronal-extracellular vesicle coordination of gliotic responses in degeneration. J Extracell Vesicles 2023; 12: e12393. https://doi.org/10.1002/jev2.12393.

[71] Hinzman CP, Singh B, Bansal S, Li Y, Iliuk A, Girgis M, et al. A multi-omics approach identifies pancreatic cancer cell extracellular vesicles as mediators of the unfolded protein response in normal pancreatic epithelial cells. J Extracell Vesicles 2022; 11: e12232. https://doi.org/10.1002/jev2.12232.

[72] Yan W, Wu X, Zhou W, Fong MY, Cao M, Liu J, et al. Cancer-cell-secreted exosomal mir-105 promotes tumour growth through the myc-dependent metabolic reprogramming of stromal cells. Nat Cell Biol 2018; 20: 597-609. https://doi.org/10.1038/s41556-018-0083-6.

[73] Xu W, Xu M, Wang L, Zhou W, Xiang R, Shi Y, et al. Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers. Signal Transduct Target Ther 2019; 4: 55. https://doi.org/10.1038/s41392-019-0081-6.

[74] Shaba E, Vantaggiato L, Governini L, Haxhiu A, Sebastiani G, Fignani D, et al. Multi-omics integrative approach of extracellular vesicles: a future challenging milestone. Proteomes 2022; 10: 10. https://doi.org/10.3390/proteomes10020012.

[75] Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature 2015; 527: 329-35. https://doi.org/10.1038/nature15756.

[76] Zhang H, Ma Y, Cheng X, Wu D, Huang X, Chen B, et al. Targeting epigenetically maladapted vascular niche alleviates liver fibrosis in nonalcoholic steatohepatitis. Sci Transl Med 2021; 13: eabd1206. https://doi.org/10.1126/scitranslmed.abd1206.

[77] Ma L, Lyu W, Song Y, Chen K, Lv L, Yang H, et al. Anti-inflammatory effect of clostridium butyricum-derived extracellular vesicles in ulcerative colitis: impact on host micrornas expressions and gut microbiome profiles. Mol Nutr Food Res 2023; 67: e2200884. https://doi.org/10.1002/mnfr.202200884.

[78] Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012; 64: 1697-707. https://doi.org/10.1002/art.34453.

[79] Pan J, Zhou X, Li W, Novotny JE, Doty SB, Wang L. In situ measurement of transport between subchondral bone and articular cartilage. J Orthop Res 2009; 27: 1347-52. https://doi.org/10.1002/jor.20883.

[80] Hu Y, Chen X, Wang S, Jing Y, Su J. Subchondral bone microenvironment in osteoarthritis and pain. Bone Res 2021; 9: 20. https://doi.org/10.1038/s41413-021-00147-z.

[81] Maldonado M, Nam J. The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis. Biomed Res Int 2013; 2013: 284873. https://doi.org/10.1155/2013/284873.

[82] Siddiq MAB, Oo WM, Hunter DJ. New therapeutic strategies in osteoarthritis. Joint Bone Spine 2024; 91: 105739. https://doi.org/10.1016/j.jbspin.2024.105739.

[83] Tong L, Yu H, Huang X, Shen J, Xiao G, Chen L, et al. Current understanding of osteoarthritis pathogenesis and relevant new approaches. Bone Res 2022; 10: 60. https://doi.org/10.1038/s41413-022-00226-9.

[84] Jiang Y. Osteoarthritis year in review 2021: biology. Osteoarthr Cartil 2022; 30: 207-15. https://doi.org/10.1016/j.joca.2021.11.009.

[85] Jeon OH, Kim C, Laberge RM, Demaria M, Rathod S, Vasserot AP, et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat Med 2017; 23: 775-81. https://doi.org/10.1038/nm.4324.

[86] Miller RE, Belmadani A, Ishihara S, Tran PB, Ren D, Miller RJ, et al. Damage-associated molecular patterns generated in osteoarthritis directly excite murine nociceptive neurons through toll-like receptor 4. Arthritis Rheumatol 2015; 67: 2933-43. https://doi.org/10.1002/art.39291.

[87] Latourte A, Kloppenburg M, Richette P. Emerging pharmaceutical therapies for osteoarthritis. Nat Rev Rheumatol 2020; 16: 673-88. https://doi.org/10.1038/s41584-020-00518-6.

[88] Liu B, Xian Y, Chen X, Shi Y, Dong J, Yang L, et al. Inflammatory fibroblast-like synoviocyte-derived exosomes aggravate osteoarthritis via enhancing macrophage glycolysis. Adv Sci (Weinh) 2024; 11: e2307338. https://doi.org/10.1002/advs.202307338.

[89] Yan J, Shen M, Sui B, Lu W, Han X, Wan Q, et al. Autophagic lc3(+) calcified extracellular vesicles initiate cartilage calcification in osteoarthritis. Sci Adv 2022; 8: eabn1556. https://doi.org/10.1126/sciadv.abn1556.

[90] Sanjurjo-Rodríguez C, Crossland RE, Reis M, Pandit H, Wang XN, Jones E. Characterization and mirna profiling of extracellular vesicles from human osteoarthritic subchondral bone multipotential stromal cells (mscs). Stem Cells Int 2021; 2021: 7232773. https://doi.org/10.1155/2021/7232773.

[91] Kim JY, Rhim WK, Lee SY, Park JM, Song DH, Cha SG, et al. Hybrid nanoparticle engineered with transforming growth factor-β1-overexpressed extracellular vesicle and cartilage-targeted anti-inflammatory liposome for osteoarthritis. ACS Nano 2024; 18: 33937-52. https://doi.org/10.1021/acsnano.4c07992.

[92] Cai Y, Wu C, Ou Q, Zeng M, Xue S, Chen J, et al. Enhanced osteoarthritis therapy by nanoengineered mesenchymal stem cells using biomimetic cus nanoparticles loaded with plasmid DNA encoding tgf-β1. Bioact Mater 2023; 19: 444-57. https://doi.org/10.1016/j.bioactmat.2022.04.021.

[93] Chang L, Yao H, Yao Z, Ho KK, Ong MT, Dai B, et al. Comprehensive analysis of key genes, signaling pathways and mirnas in human knee osteoarthritis: based on bioinformatics. Front Pharmacol 2021; 12: 730587. https://doi.org/10.3389/fphar.2021.730587.

[94] Wang Y, Shen S, Li Z, Li W, Weng X. Mir-140-5p affects chondrocyte proliferation, apoptosis, and inflammation by targeting hmgb1 in osteoarthritis. Inflamm Res 2020; 69: 63-73. https://doi.org/10.1007/s00011-019-01294-0.

[95] Lin T, Wu N, Wang L, Zhang R, Pan R, Chen YF. Inhibition of chondrocyte apoptosis in a rat model of osteoarthritis by exosomes derived from mir-140-5p-overexpressing human dental pulp stem cells. Int J Mol Med 2021; 47: 7. https://doi.org/10.3892/ijmm.2020.4840.

[96] Ye P, Mi Z, Wei D, Gao P, Ma M, Yang H. Mir-3960 from mesenchymal stem cell-derived extracellular vesicles inactivates sdc1/wnt/β-catenin axis to relieve chondrocyte injury in osteoarthritis by targeting phlda2. Stem Cells Int 2022; 2022: 9455152. https://doi.org/10.1155/2022/9455152.

[97] Wang H, Zhang Y, Zhang C, Zhao Y, Shu J, Tang X. Exosomes derived from mir-146a-overexpressing fibroblast-like synoviocytes in cartilage degradation and macrophage m1 polarization: a novel protective agent for osteoarthritis? Front Immunol 2024; 15: 1361606. https://doi.org/10.3389/fimmu.2024.1361606.

[98] Yuan Q, Yang M, Zheng H, Cai Y, Luo P, Wang X, et al. M2 macrophage-derived extracellular vesicles encapsulated in hyaluronic acid alleviate osteoarthritis by modulating macrophage polarization. ACS Biomater Sci Eng 2024; 10: 3355-77. https://doi.org/10.1021/acsbiomaterials.3c01833.

[99] Wang Y, Zhao M, Li W, Yang Y, Zhang Z, Ma R, et al. Bmsc-derived small extracellular vesicles induce cartilage reconstruction of temporomandibular joint osteoarthritis via autotaxin-yap signaling axis. Front Cell Dev Biol 2021; 9: 656153. https://doi.org/10.3389/fcell.2021.656153.

[100] Tavallaee G, Lively S, Rockel JS, Ali SA, Im M, Sarda C, et al. Contribution of microrna-27b-3p to synovial fibrotic responses in knee osteoarthritis. Arthritis Rheumatol. 2022; 74: 1928-42. https://doi.org/10.1002/art.42285.

[101] Endisha H, Datta P, Sharma A, Nakamura S, Rossomacha E, Younan C, et al. Microrna-34a-5p promotes joint destruction during osteoarthritis. Arthritis Rheumatol 2021; 73: 426-39. https://doi.org/10.1002/art.41552.

[102] Boere J, van de Lest CH, Libregts SF, Arkesteijn GJ, Geerts WJ, Nolte-’t Hoen EN, et al. Synovial fluid pretreatment with hyaluronidase facilitates isolation of cd44+ extracellular vesicles. J Extracell Vesicles 2016; 5: 31751. https://doi.org/10.3402/jev.v5.31751.

[103] Kato T, Miyaki S, Ishitobi H, Nakamura Y, Nakasa T, Lotz MK, et al. Exosomes from il-1β stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes. Arthritis Res Ther 2014; 16: R163. https://doi.org/10.1186/ar4679.

[104] Mustonen AM, Lehmonen N, Paakkonen T, Raekallio M, Käkelä R, Niemelä T, et al. Equine osteoarthritis modifies fatty acid signatures in synovial fluid and its extracellular vesicles. Arthritis Res Ther 2023; 25: 39. https://doi.org/10.1186/s13075-023-02998-9.

[105] Zhang X, Ma S, Naz SI, Jain V, Soderblom EJ, Aliferis C, et al. Comprehensive characterization of pathogenic synovial fluid extracellular vesicles from knee osteoarthritis. Clin Immunol 2023; 257: 109812. https://doi.org/10.1016/j.clim.2023.109812.

[106] Anderson JR, Jacobsen S, Walters M, Bundgaard L, Diendorfer A, Hackl M, et al. Small non-coding rna landscape of extracellular vesicles from a post-traumatic model of equine osteoarthritis. Front Vet Sci 2022; 9: 901269. https://doi.org/10.3389/fvets.2022.901269.

[107] Meng F, Li Z, Zhang Z, Yang Z, Kang Y, Zhao X, et al. Microrna-193b-3p regulates chondrogenesis and chondrocyte metabolism by targeting hdac3. Theranostics 2018; 8: 2862-83. https://doi.org/10.7150/thno.23547.

[108] Tsuno H, Arito M, Suematsu N, Sato T, Hashimoto A, Matsui T, et al. A proteomic analysis of serum-derived exosomes in rheumatoid arthritis. BMC Rheumatol 2018; 2: 35. https://doi.org/10.1186/s41927-018-0041-8.

[109] Zhang X, Huebner JL, Kraus VB. Extracellular vesicles as biological indicators and potential sources of autologous therapeutics in osteoarthritis. Int J Mol Sci 2021; 22: 22. https://doi.org/10.3390/ijms22158351.

[110] Zhao Y, Xu J. Synovial fluid-derived exosomal lncrna pcgem1 as biomarker for the different stages of osteoarthritis. Int Orthop 2018; 42: 2865-72. https://doi.org/10.1007/s00264-018-4093-6.

[111] Jeon OH, Wilson DR, Clement CC, Rathod S, Cherry C, Powell B, et al. Senescence cell-associated extracellular vesicles serve as osteoarthritis disease and therapeutic markers. JCI Insight 2019; 4: e125019. https://doi.org/10.1172/jci.insight.125019.

[112] Tao SC, Yuan T, Zhang YL, Yin WJ, Guo SC, Zhang CQ. Exosomes derived from mir-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics 2017; 7: 180-95. https://doi.org/10.7150/thno.17133.

[113] Wu J, Wu J, Xiang W, Gong Y, Feng D, Fang S, et al. Engineering exosomes derived from tnf-α preconditioned ipfp-mscs enhance both yield and therapeutic efficacy for osteoarthritis. J Nanobiotechnol 2024; 22: 555. https://doi.org/10.1186/s12951-024-02795-9.

[114] Wang T, Fang X, Zhao H, Zhang Y, Li Y, Li Z, et al. Small extracellular vesicles from 3d pcl/ha scaffold-cultured and emf-stimulated bmscs promote lumbar fusion via pten/pi3k/akt pathway. Composites Part B 2025; 294: 112165. https://doi.org/10.1016/j.compositesb.2025.112165.

[115] Srinivasan S, Yeri A, Cheah PS, Chung A, Danielson K, De Hoff P, et al. Small rna sequencing across diverse biofluids identifies optimal methods for exrna isolation. Cell 2019; 177: 446-62.e16. https://doi.org/10.1016/j.cell.2019.03.024.

[116] Reiner AT, Witwer KW, van Balkom BWM, de Beer J, Brodie C, Corteling RL, et al. Concise review: developing best-practice models for the therapeutic use of extracellular vesicles. Stem Cells Transl Med 2017; 6: 1730-9. https://doi.org/10.1002/sctm.17-0055.

[117] Li J, Yang X, Chu Q, Xie L, Ding Y, Xu X, et al. Multi-omics molecular biomarkers and database of osteoarthritis. Database (Oxford) 2022; 2022: baac052. https://doi.org/10.1093/database/baac052.

[118] Bordanaba-Florit G, Royo F, Kruglik SG, Falcón-Pérez JM. Using single-vesicle technologies to unravel the heterogeneity of extracellular vesicles. Nat Protoc 2021; 16: 3163-85. https://doi.org/10.1038/s41596-021-00551-z.

[119] Sajidah ES, Lim K, Yamano T, Nishide G, Qiu Y, Yoshida T, et al. Spatiotemporal tracking of small extracellular vesicle nanotopology in response to physicochemical stresses revealed by hs-afm. J Extracell Vesicles 2022; 11:e12275. https://doi.org/10.1002/jev2.12275.

[120] Yin H, Xie J, Xing S, Lu X, Yu Y, Ren Y, et al. Machine learning-based analysis identifies and validates serum exosomal proteomic signatures for the diagnosis of colorectal cancer. Cell Rep Med 2024; 5: 101689. https://doi.org/10.1016/j.xcrm.2024.101689.